BSV:NYE-Vanguard Short-Term Bond Index Fund ETF Shares (USD)

ETF | Short-Term Bond |

Last Closing

USD 78.4

Change

-0.16 (-0.20)%

Market Cap

N/A

Volume

1.68M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Short-Term Bond

Symbol Name Price(Change) Market Cap
SPSB SPDR Barclays Short Term Corpo..

-0.05 (-0.17%)

USD 7.71B
LDUR PIMCO Enhanced Low Duration Ac..

-0.06 (-0.06%)

USD 0.86B
FLTB Fidelity® Limited Term Bond E..

-0.05 (-0.09%)

USD 0.15B
IIGD Invesco Investment Grade Defen..

-0.06 (-0.24%)

USD 0.04B
NUSA Nuveen Enhanced Yield 1-5 Year..

-0.02 (-0.09%)

USD 0.03B
LSST Natixis Loomis Sayles Short Du..

N/A

N/A

ETFs Containing BSV

TBFC The Brinsmere Fund - Cons.. 10.27 % 0.00 %

-0.12 (-0.45%)

N/A
SNUG 0.00 % 0.00 %

N/A

N/A
CLSA 0.00 % 0.00 %

N/A

N/A
CLSC 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Short-Term Bond) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.79% 71% C- 32% F
Dividend Return 2.48% 17% F 46% F
Total Return 4.27% 43% F 29% F
Trailing 12 Months  
Capital Gain 4.55% 71% C- 24% F
Dividend Return 3.30% 17% F 45% F
Total Return 7.85% 71% C- 24% F
Trailing 5 Years  
Capital Gain -3.34% 71% C- 40% F
Dividend Return 8.95% 17% F 29% F
Total Return 5.61% 57% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain -1.59% N/A N/A 28% F
Dividend Return 0.16% N/A N/A 25% F
Total Return 1.75% N/A N/A 41% F
Risk Return Profile  
Volatility (Standard Deviation) 3.68% N/A N/A 95% A
Risk Adjusted Return 4.30% N/A N/A 27% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike